NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Remedy Pharmaceuticals

Remedy Pharmaceuticals

Private
New York City, New YorkHealthcare & Life Scienceshttps://remedypharmaceuticals.com/

Last Round

Series D

Dec 1, 2015

Total Funding Raised

$16.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Remedy Pharmaceuticals is a pharmaceutical company that develops therapies for acute central nervous system conditions, including strokes and traumatic brain injuries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

clinical-stage pharmacerebral edema treatmentischemic stroke treatmentbiotechdrug repurposingLarge Hemispheric InfarctionLHIintravenous glyburideCNS injury treatmentneurotherapeuticspharma asset saleSUR1-TRPM4 inhibitororphan drug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remedy Pharmaceuticals Comparables

Compare Remedy Pharmaceuticals with similar companies based on industry and business-model similarity.

Remedy Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aeromics
91%
Pharmazz, Inc.
82%
NoNO Inc.
81%

Remedy Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DDec 1, 2015
VC RoundFeb 10, 2014
VC RoundNov 1, 2013
Series BJun 1, 2012
AngelMar 1, 2012
Financing
Sep 8, 2010

Remedy Pharmaceuticals Investors

Notable investors and investment history

Remedy Pharmaceuticals investors
InvestorRounds
The Vertical GroupSeries D
Green Circle Capital PartnersAngel, VC Round, Series B
Broadview VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 85% MoM.

  • Apr 17, 2026

    Monthly visitors grew 89% MoM, reaching 1.1K.

Remedy Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Remedy Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Remedy Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range5
Year Founded2004
Last FundingDec 1, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.